Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Amador

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
CNS Spectrums|October 24, 2025
Assessment and Treatment of Anosognosia in SchizophreniaXavier Amador
Psychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata|November 28, 2012
Poor insight in schizophrenia: implications for diagnosis and treatmentXavier Amador
Schizophrenia Research|January 22, 2023
Denial of anosognosia in schizophreniaXavier Amador
Schizophrenia Bulletin|December 18, 2010
Lessons learned about poor insightCelso Arango, Xavier Amador
Comprehensive Psychiatry|December 13, 2003
The relationship between insight and symptoms in schizophreniaSerge Sevy, Kay Nathanson, Hema Visweswaraiah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 19, 2004
Aldolase and actin protect rabbit muscle lactate dehydrogenase from ascorbate inhibitionPercy J Russell, Anita Williams, Xavier Amador, et al.
Psychological Medicine|April 22, 2005
A model of verbal memory impairments in schizophrenia: two systems and their associations with underlying cognitive processes and clinical symptomsGildas Brébion, Jack M Gorman, Dolores Malaspina, et al.
Psychiatry Research|October 16, 2002
Source monitoring impairments in schizophrenia: characterisation and associations with positive and negative symptomatologyGildas Brébion, Jack M Gorman, Xavier Amador, et al.
International Clinical Psychopharmacology|May 12, 2006
Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidoneGeorges M Gharabawi, Robert A Lasser, Cynthia A Bossie, et al.
Schizophrenia Research|April 17, 2007
Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS)Raymond R Goetz, Cheryl Corcoran, Scott Yale, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
CNS Spectrums|October 24, 2025
Assessment and Treatment of Anosognosia in SchizophreniaXavier Amador
Psychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata|November 28, 2012
Poor insight in schizophrenia: implications for diagnosis and treatmentXavier Amador
Schizophrenia Research|January 22, 2023
Denial of anosognosia in schizophreniaXavier Amador
Schizophrenia Bulletin|December 18, 2010
Lessons learned about poor insightCelso Arango, Xavier Amador
Comprehensive Psychiatry|December 13, 2003
The relationship between insight and symptoms in schizophreniaSerge Sevy, Kay Nathanson, Hema Visweswaraiah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 19, 2004
Aldolase and actin protect rabbit muscle lactate dehydrogenase from ascorbate inhibitionPercy J Russell, Anita Williams, Xavier Amador, et al.
Psychological Medicine|April 22, 2005
A model of verbal memory impairments in schizophrenia: two systems and their associations with underlying cognitive processes and clinical symptomsGildas Brébion, Jack M Gorman, Dolores Malaspina, et al.
Psychiatry Research|October 16, 2002
Source monitoring impairments in schizophrenia: characterisation and associations with positive and negative symptomatologyGildas Brébion, Jack M Gorman, Xavier Amador, et al.
International Clinical Psychopharmacology|May 12, 2006
Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidoneGeorges M Gharabawi, Robert A Lasser, Cynthia A Bossie, et al.
Schizophrenia Research|April 17, 2007
Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS)Raymond R Goetz, Cheryl Corcoran, Scott Yale, et al.
Pageof 2